What`s New - Faculty of Medicine

What’s New
Volume 3, No 1
January 2011
McGill-CIHR Drug Development Training Program
Important Dates:
The DDTP Lung Cancer Drug Development Symposium
April 18, 2011
DDTP Symposium
“The impact of Molecular Recognition in Drug Discovery”
The second DDTP symposium of the academic year took place on October 8, 2010 at the McGill Faculty Club,
with the participation of a group of collaborating experts on lung cancer treatment and drug discovery from the
Dana Farber Cancer Institute of the Harvard Medical school. Chaired by Dr. Bertrand Jean-Claude, the
session begun with a lecture by Dr. Pasi Jänne on the benefits and limitations of the current therapies in the
(Continued on page 2)
April 15, 2011
DDTP Spring Competition
Deadline
Inside this issue:
From left to right: Dr. Kwok-Kin Wong, MD, Ph.D., invited speaker, Dr. Pasi Jänne, MD, Ph.D.. invited
speaker, Dr. Bertrand Jean-Claude, Ph.D., session chair and DDTP co-director, Dr. Nathanael Gray, Ph.D.
invited speaker, and Dr. Youla Tsantrizos, Ph.D. Chair of the DDTP Workshop and Seminar Development
DDTP Lung Cancer Symposium
1
Fall 2010 Scholarship and
Fellowship Competition Re-
1
Upcoming DDTP Symposium:
The Impact of Molecular Recognition in Drug Discovery
2
Invitation to Acknowledge
CIHR and DDTP in Publications and Poster Presentations
3
Travel Grant Awardee
3
Fall 2010 Scholarship and Fellowship Competition Results
The Scholarship and Fellowship committee has reviewed and ranked 30 applications received from the
Departments of Chemistry (14), Pharmacology (8) and Medicine (8). A total of 17 trainees have been selected,
giving a success rate of 56% in this third competition. Of the 17 funded trainees, 7 are from the Department of
Chemistry (41%), 6 from Medicine (35%) and 4 from Pharmacology (24%). The awards were granted to 3
Master’s, 10 Ph.D. students and 4 post-doctoral fellows. This increases the number of DDTP trainees in the
program to 24 in total.
(Continued on page 2)
January 2011
What’s New
DDTP Lung Cancer Symposium (continued)
(Continued from page 1)
clinical management of lung cancer, followed by Dr. Kwok-King Wong who discussed the use of genetically
engineering mouse models for testing novel therapeutics. Dr. Wong described the new mouse hospital of the
Dana Farber Cancer Institute designed to mimic human cancer treatment from drug administration to
sophisticated imaging techniques such as small animal MRI and PET imaging. The drug design aspect of the
symposium was presented by Dr. Nathanael Gray, a medicinal chemist, who discussed the rational drug
design approaches for identifying selective protein kinase inhibitors.
The symposium was highly multidisciplinary, covering several aspects of drug development including
medicinal chemistry, drug design, animal models and clinical testing. The session was well animated and well
attended. The DDTP Office recorded a total of 83 registrants and 70 attendants.
The Workshop and Seminar Development committee and the DDTP thank all the speakers for their excellent
lectures and all the participants who, through their numerous questions, contributed to a very animated
session.
Fall 2010 Scholarship and Fellowship Competition Results (continued)
Deadline Reminder:
April 15, 2011
Scholarship and Fellowship Competition,
All documents must be
submitted by 11:59 PM.
(Continued from page 1)
Three of the new trainees are being funded by the new Oncology Training Fund, created with a donation from
Pfizer and dedicated to support cancer research.
Also awarded during the competition was the Maysie Mac Sporran scholarship from the Faculty of Medicine.
The scholarship is awarded to a top-ranked student in official training programs of the Canadian Institutes of
Health Research. Irina Glazkova from Dr. Terence Hebert’s lab in the department of Pharmacology &
Therapeutics was presented the scholarship in conjunction with a DDTP scholarship based on the exceptional
quality of her application. It should be noted that Irina Glazkova is the second student from Dr. Hebert’s Lab to
receive the Maysie Mac Sporran award.
On behalf of the DDTP, we congratulate all the successful candidates and wish them a productive upcoming
year.
We thank the Canadian Institutes of Health Research (CIHR), Pfizer, and the MUHC Research Institute for
funding the awards granted in this competition.
Click here for result details
Upcoming DDTP Symposium, Monday, April 18, 2011:
The Impact of Molecular Recognition in Drug Discovery
Plenary Lectures by:
Date:
Monday, April 18, 2011
Dr. Francois Diederich, ETH Zurich
Time:
8:30 AM to 12:00 Noon
Dr. Christopher Bayly, Merck Frosst
Place: Faculty Club, McGill University
2
Dr. James G. Omichinski, Université de Montréal
What’s New
IMPORTANT NOTICE
Acknowledgement of CIHR and DDTP in Publications and Poster Presentations
Trainees supported by the DDTP (i.e. scholarship, fellowship and travel award grantees) are required to acknowledge funding from the program in all publications, abstracts, posters or events. For background information on how to acknowledge the funding, please click on http://www.cihr-irsc.gc.ca/e/30789.html.
Below are the main points to remember when publishing or presenting your work:
1. Always acknowledge the Canadian Institutes of Health Research (CIHR) and the Drug Development Training Program (DDTP).
2. When using the CIHR logo, notify CIHR at [email protected] to justify your use of their logo.
3. Always forward to the DDTP office at [email protected] a copy of your publications/abstracts or
the relevant information for posters and events.
Should you have any question, please do not hesitate to contact Aube Mamias, DDTP administrator.
Travel Grant Awardees
On behalf of the scholarship and fellowship committee, we are pleased to announce the third travel awardee of
the DDTP (see complete list of awardees). Irina Glazkova (supervisor: Dr. Terry Hebert) received funding to
present a poster on the proteomics approach to identify novel interacting partners of β2-Adrenergic receptors at
the Great Lakes 2010 GPCR Meeting in Toronto.
Applications for travel awards can be submitted at any time and results are disclosed approximately one month
following receipt of the application. For more information, please see the guidelines.
Invitation to an ACFAS Medicinal Chemistry Symposium in May 2011:
A Message from the Organizing Committee
Nous vous confirmons par la présente la tenue du colloque de chimie médicinale de la prochaine conférence
de l'ACFAS, qui aura lieu à Sherbrooke du 9 au 13 mai 2011.
À l'image de la chimie médicinale, nous aimerions faire de ce colloque un lieu de rencontre dynamique où les
spécialistes de la chimie médicinale et des disciplines reliées viennent échanger sur leurs récentes découvertes. Pour ce faire, merci de diffuser ce courriel et d'afficher l'annonce aussi largement que possible auprès de
vos collègues et départements respectifs. Le pamphlet vous donnera les informations pertinentes à la soumission de résumés. Les présentations de professeurs et d'étudiants gradués seront considérées.
La date limite de soumission des résumés est le 31 janvier 2011, n'attendez pas la dernière minute!
dant de vous compter parmi nous pour ce colloque qui s'annonce riche en échanges.
Prof. Éric Marsault (U. Sherbrooke)
Prof. Yves Dory (U. Sherbrooke)
Prof. Emanuel Esther (U. Sherbrooke)
3
En atten-